Regulation of macrophage phagocytosis of apoptotic cells by cAMP

A G Rossi1, J C McCutcheon, N Roy

  • 1Department of Medicine (RIE), Rayne Laboratory, The University of Edinburgh Medical School, Scotland, UK. a.g.rossi@ed.ac.uk

Insights

Prostaglandins E2 and D2, which increase cyclic AMP (cAMP) levels, reduce macrophage phagocytosis of apoptotic cells. This suggests cAMP signaling regulates inflammation resolution and offers a therapeutic target.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Macrophage phagocytosis of apoptotic cells is crucial for resolving inflammation and preventing tissue damage.
  • The regulatory and signaling mechanisms controlling this phagocytic process are not well understood.

Purpose of the Study:

  • To investigate the effects of prostaglandins (PGs) and agents that elevate intracellular cyclic adenosine monophosphate (cAMP) on the phagocytic capacity of human monocyte-derived macrophages.
  • To explore the role of cAMP signaling pathways in regulating macrophage-mediated clearance of apoptotic cells.

Main Methods:

  • Human monocyte-derived macrophages were treated with PGE2, PGD2, cAMP analogues (dibutyryl-cAMP, 8-bromo-cAMP), and a cGMP analogue (dibutyryl-GMP).
  • Phagocytosis of apoptotic cells and Ig-opsonized erythrocytes was assessed.
  • Intracellular cAMP levels and macrophage morphology were analyzed following PGE2 treatment.

Main Results:

  • PGE2 and PGD2 significantly reduced the proportion of macrophages phagocytosing apoptotic cells.
  • Elevating intracellular cAMP with analogues mimicked this inhibitory effect, while cGMP analogues had no impact.
  • PGE2 treatment led to a rapid, transient increase in intracellular cAMP levels.
  • Macrophage phagocytosis of Ig-opsonized erythrocytes remained unaffected, indicating specificity.
  • cAMP elevation induced changes in macrophage morphology, suggesting altered adhesive properties.

Conclusions:

  • Activation of cAMP signaling pathways by inflammatory mediators like PGs regulates macrophage phagocytosis of apoptotic cells.
  • This regulation plays a role in limiting tissue injury during inflammation.
  • Modulation of cAMP levels presents a potential therapeutic strategy for controlling inflammation resolution.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...